Ge Long Hui·2025-11-01 23:05Summary of Key Points Core Viewpoint - Several companies are experiencing significant shareholder reductions, with some facing regulatory scrutiny for financial discrepancies [1] Group 1: Shareholder Reductions - Aohua Endoscopy's general manager Gu Xiaozhou plans to reduce holdings by no more than 2.6 million shares [1] - Tuosida's senior executive Huang Daibo intends to reduce holdings by no more than 0.9524% of shares [1] - Anke Intelligent Electric's actual controller Chen Xiaohui plans to reduce holdings by no more than 1% [1] - Shanhe Pharmaceutical's shareholder Fosun Pharma intends to reduce holdings by no more than 3% [1] - Digital Certification's shareholder Capital Information Development plans to reduce holdings by no more than 2% [1] - Saiwu Technology's shareholder Dongyun Chuangtou plans to reduce holdings by no more than 1% [1] - Kanglongda's shareholder Juyin Fund plans to reduce holdings by no more than 3% [1] - Zaiseng Technology's controlling shareholder Guo Mao has cumulatively reduced 9.45 million shares [1] - Weishi Electronics' controlling shareholder Watanabe Yōichi has reduced 0.89% of company shares [1] - Olin Bio's shareholder Shanghai Wushan has cumulatively reduced 3% of company shares [1] Group 2: Other Notable Events - Taifeng Pump Industry has terminated plans for a major asset restructuring [1] - Qingyue Technology is under investigation by the Securities Regulatory Commission for suspected false financial reporting [1] - Baismei's actual controller has received a notice of investigation from the Securities Regulatory Commission [1] - Taiyuan Car Factory will implement other risk warnings starting November 4 [1] - First Capital's subsidiary Yichuang Investment Bank has received a notice of investigation from the Securities Regulatory Commission [1]